HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children - BioSpace
• HCA Healthcare has announced a new study published in the New England Journal of Medicine (NEJM) highlighting advancements in CRISPR-based therapies for children. • The research builds upon pioneering work at TriStar Centennial Medical Center and the Sarah Cannon Transplant and Cellular Therapy Network, which performs over 1,600 cellular therapies and transplants annually. • Dr. Frangoul, a key investigator, previously contributed to the first U.S. clinical trial for gene-editing in sickle cell disease, leading to the first FDA-approved CRISPR therapy.
biospace.com-Samsung-Electronics-Chairman-Lee-Jae-yong-(R)-and-SK-Group.jpeg%3Ftrim%3D0%2C57%2C0%2C57%26width%3D1200%26height%3D800%26crop%3D1200%3A800&w=1920&q=85)










